Crestwood Advisors Group’s Niagen Bioscience, Inc. Common Stock NAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-11,857
| Closed | -$81.8K | – | 541 |
|
|
2025
Q1 | $81.8K | Buy |
11,857
+86
| +0.7% | +$593 | ﹤0.01% | 489 |
|
|
2024
Q4 | $62.4K | Sell |
11,771
-120
| -1% | -$637 | ﹤0.01% | 452 |
|
|
2024
Q3 | $43.4K | Sell |
11,891
-154
| -1% | -$562 | ﹤0.01% | 440 |
|
|
2024
Q2 | $32.9K | Sell |
12,045
-9,903
| -45% | -$27K | ﹤0.01% | 423 |
|
|
2024
Q1 | $76.4K | Sell |
21,948
-75
| -0.3% | -$261 | ﹤0.01% | 413 |
|
|
2023
Q4 | $31.5K | Hold |
22,023
| – | – | ﹤0.01% | 403 |
|
|
2023
Q3 | $32.2K | Hold |
22,023
| – | – | ﹤0.01% | 364 |
|
|
2023
Q2 | $34.6K | Hold |
22,023
| – | – | ﹤0.01% | 253 |
|
|
2023
Q1 | $33.7K | Sell |
22,023
-15,902
| -42% | -$24.3K | ﹤0.01% | 257 |
|
|
2022
Q4 | $63.7K | Hold |
37,925
| – | – | ﹤0.01% | 258 |
|
|
2022
Q3 | $47K | Buy |
37,925
+1,641
| +5% | +$2.03K | ﹤0.01% | 255 |
|
|
2022
Q2 | $61K | Buy |
36,284
+1,925
| +6% | +$3.24K | ﹤0.01% | 253 |
|
|
2022
Q1 | $85K | Buy |
+34,359
| New | +$85K | ﹤0.01% | 277 |
|